Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital
D. Zaharia (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), A. Andru (Bucuresti, Romania), N. Chelaru (Bucuresti, Romania), O. Grigore (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania)
Source: Virtual Congress 2021 – COVID - 19 around the globe
Session: COVID - 19 around the globe
Session type: E-poster
Number: 3805
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Zaharia (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), A. Andru (Bucuresti, Romania), N. Chelaru (Bucuresti, Romania), O. Grigore (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania). Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital. 3805
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021
Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk Source: Virtual Congress 2021 – COVID - 19 Year: 2021
Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission Source: Virtual Congress 2021 – Long COVID - 19 Year: 2021
Risk factors and outcomes for different wheezing phenotypes at five years of age in an Aberdeen birth cohort Source: Eur Respir J 2005; 26: Suppl. 49, 502s Year: 2005
Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Prevalence rate and risk factors for hospital readmissions for asthma in children and adolescents in a tropical setting Source: Eur Respir J 2002; 20: Suppl. 38, 535s Year: 2002
Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019 Year: 2019
Safety and risk factors for the morbidity and mortality of pneumonectomies: a retrospective 10-year study in a single institution Source: Virtual Congress 2020 – Thoracic surgery: malignancies Year: 2020
Analysis of the risk factors related to in-hospital deaths in patients with tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 504s Year: 2006
Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei Source: Annual Congress 2007 - Tuberculosis control Year: 2007
Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010
EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE) Source: Annual Congress 2010 - COPD exacerbation Year: 2010
Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010
Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021
Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Mortality risk in a Romanian cohort of patients hospitalised for COVID-19 Source: Virtual Congress 2021 – COVID - 19 around the globe Year: 2021
Analysis of patients with COPD requiring mechanical ventilation: characteristics, outcomes and risk factors for hospital mortality Source: Annual Congress 2009 - Intensive care unit management and outcome Year: 2009